Cryptococcosis-Pipeline Review, H1 2015

Cryptococcosis-Pipeline Review, H1 2015

  • Products Id :- GMDHC6444IDB
  • |
  • Pages: 23
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cryptococcosis-Pipeline Review, H1 2015


Global Markets Direct's, 'Cryptococcosis-Pipeline Review, H1 2015', provides an overview of the Cryptococcosis's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Cryptococcosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cryptococcosis and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides a snapshot of the global therapeutic landscape of Cryptococcosis

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Cryptococcosis and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Cryptococcosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Cryptococcosis pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Cryptococcosis

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Cryptococcosis pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Introduction 4

Global Markets Direct Report Coverage 4

Cryptococcosis Overview 5

Therapeutics Development 6

Pipeline Products for Cryptococcosis-Overview 6

Pipeline Products for Cryptococcosis-Comparative Analysis 7

Cryptococcosis-Therapeutics under Investigation by Universities/Institutes 8

Cryptococcosis-Pipeline Products Glance 9

Early Stage Products 9

Cryptococcosis-Products under Investigation by Universities/Institutes 10

Cryptococcosis-Therapeutics Assessment 11

Assessment by Monotherapy Products 11

Assessment by Target 12

Assessment by Mechanism of Action 13

Assessment by Molecule Type 14

Drug Profiles 15

fluorcombstatin-Drug Profile 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

Small Molecule for Candidiasis and Cryptococcosis-Drug Profile 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Small Molecule for Cryptococcosis and Candidiasis-Drug Profile 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Small Molecule for Fungal Infections-Drug Profile 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Small Molecule for Infectious Diseases-Drug Profile 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

Small Molecules for Cryptococcosis-Drug Profile 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Cryptococcosis-Dormant Projects 21

Appendix 22

Methodology 22

Coverage 22

Secondary Research 22

Primary Research 22

Expert Panel Validation 22

Contact Us 22

Disclaimer 23

List of Tables

Number of Products under Development for Cryptococcosis, H1 2015 6

Number of Products under Development for Cryptococcosis-Comparative Analysis, H1 2015 7

Number of Products under Investigation by Universities/Institutes, H1 2015 8

Comparative Analysis by Early Stage Development, H1 2015 9

Products under Investigation by Universities/Institutes, H1 2015 10

Assessment by Monotherapy Products, H1 2015 11

Number of Products by Stage and Target, H1 2015 12

Number of Products by Stage and Mechanism of Action, H1 2015 13

Number of Products by Stage and Molecule Type, H1 2015 14

Cryptococcosis-Dormant Projects, H1 2015 21

List of Figures

Number of Products under Development for Cryptococcosis, H1 2015 6

Number of Products under Development for Cryptococcosis-Comparative Analysis, H1 2015 7

Number of Products under Investigation by Universities/Institutes, H1 2015 8

Comparative Analysis by Early Stage Products, H1 2015 9

Assessment by Monotherapy Products, H1 2015 11

Number of Products by Stage and Top 10 Molecule Types, H1 2015 14

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Cryptococcosis Therapeutic Products under Development, Key Players in Cryptococcosis Therapeutics, Cryptococcosis Pipeline Overview, Cryptococcosis Pipeline, Cryptococcosis Pipeline Assessment

select a license

Single User License
USD 2000 INR 135460
Site License
USD 4000 INR 270920
Corporate User License
USD 6000 INR 406380



Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]